Business Wire: July 14, 2016 – MONTGOMERY, TX, U.S.A. – AngioSoma, Inc. (OTCQB: SOAN), previously known as First Titan Corp. (the “company,” “we,” and “our”), changed our corporate name and focus to that of a clinical-stage biopharmaceutical company, introducing an exciting new treatment for one of…
